WHO’s latest hepatitis B vaccination guidelines emphasize universal infant immunization to prevent transmission. The most recent position paper, updated in 2024, prioritizes timely birth dosing and catch-up vaccination. All infants receive the first monovalent HBV vaccine dose within 24 hours of birth, even if they are premature or low birth weight. This is followed by 2 to 3 additional doses (3- or 4-dose series total) at least 4 weeks apart to complete the primary series.
Hepatitis B Vaccination Schedule
Schedules
Infants
Birth dose (0), then one month, six months (3 doses); or integrated into pentavalent vaccine at 6, 10, 14 weeks (4-dose equivalent).
Or
Birth dose: Single dose of Hepatitis B vaccine within 24 hours of birth (given along with BCG and OPV-0 at birth)
6 weeks: First primary dose, usually as part of the pentavalent or hexavalent vaccine (which includes DTP, Hib, and Hepatitis B).
10 weeks: Secondary primary dose (same combination vaccine)
14 weeks: Third primary dose (same combination vaccine).
In some children or areas, minor variations such as birth, 6, 10, and 14 weeks or birth, 1, and 6 months are also accepted as protective schedules under the universal immunization program.
Minimum Intervals
Minimum intervals: 4 weeks between doses 1-2 and 2-3; the birth dose for preterm infants doesn’t count toward the series.
Catch-up Vaccination
Prioritize unvaccinated children and adolescents born before universal programs. High-risk adults (e.g., healthcare workers, HIV patients, diabetics) should get vaccinated; no routine pre/post-testing unless cost-effective.
Unvaccinated older children and adolescents: A 3-dose schedule at 0, 1 month, and 6 months (each dose 1 ml intramuscular) is recommended.
High-risk adults: the same 3 doses as above.
Post-exposure (babies born to hepatitis B-positive mothers): the birth-dose hepatitis B vaccine is mandatory within 24 hours, often combined with hepatitis B immunoglobulin (HBIG) when indicated.
Booster Policy and Monitoring
Boosters and Groups: No routine boosters are needed post-series, as protection lasts 20+ years, likely lifelong. Vaccinate all healthcare workers and those in moderate/low prevalence areas via catch-up.
Monitoring: Track timely birth dose coverage (within 24 hours) and HBsAg prevalence. For mother-to-child prevention, add antivirals if needed alongside the vaccine.
Schedule for Preterm Infants
Administer the monovalent HepB vaccine as the birth dose (dose 1) within 24 hours for preterm infants (before 37 weeks gestation) if medically stable. Follow with a 3- or 4-dose completion series, typically at 1 month, 6 months (3 doses), or integrated into a routine schedule at 6, 10, or 14 weeks (4 doses equivalent).
The birth dose counts toward the series even for very low birth weight infants (<2000 g), but ensure minimum intervals (4 weeks between doses 1-2 and 2-3).
Hepatitis B Vaccine Side Effects
In India, the hepatitis B vaccine (including recombinant DNA and pentavalent/hexavalent combination vaccines) is generally safe, but like all vaccines, it can cause some side effects and needs certain precautions.
Common Side Effects
Local reactions at injection site: mild pain, redness, swelling, or soreness, usually lasting 1-2 days.
Mild systemic effects: low-grade fever, tiredness or malaise, headache, mild muscle pain, or brief irritability in infants.
These are usually self-limited and need only rest, fluids, and simple paracetamol if fever or pain is bothersome.
Less Common and Rare Reactions
Nausea, vomiting, diarrhea, or mild abdominal pain occurs infrequently and resolves without treatment.
Rarely, rash, urticaria (hives), joint pain, or transient abnormal liver-function tests may appear; these still are uncommon and usually resolve.
Serious Side Effects Requiring Urgent Care
Severe allergic reaction (anaphylaxis): very rare but potentially life-threatening; symptoms include
Hives, swelling of face/lips/tongue/throat
Difficulty breathing, rapid heartbeat, dizziness, or fainting.
If any of these appear within minutes to hours after vaccination, seek emergency medical care immediately.
Precautions and Who Should Be Cautious
Avoid or delay if: There is a history of severe allergic reaction (anaphylaxis) to a previous Hepatitis B-containing vaccine or any component (especially yeast, used in recombinant DNA vaccines).
Use with caution in: persons with acute severe febrile illness; vaccination is usually postponed until they recover, but routine mild colds or low-grade fever is not a reason to avoid it. Pregnant or breastfeeding women only if clearly indicated by a doctor. In India the vaccine is considered safe when benefits outweigh risks in high-risk situations.
General Advice in Indian Practice
Observe the person for 15 to 30 minutes after injection in a medical setting to catch any immediate allergic reaction.
Complete the full schedule (birth + 6, 10, 14 weeks or 0-1-6 month series as per age) even if minor side effects occur, because serious complications are very rare and protection against Hepatitis B is crucial.
Effectiveness and Efficacy of the Hepatitis B Vaccine in India
The Hepatitis B vaccine in India is highly effective at preventing chronic infection and reducing transmission, especially when the birth dose and full 3-4 dose schedule are completed, though real-world effectiveness varies somewhat by age and program coverage.
Efficacy (Laboratory Studies and Global Data)
In global studies, a complete 3-dose hepatitis B vaccine series protects more than 95% of healthy infants, children, and young adults from chronic infection when given according to schedule.
The vaccine is strongly effective in preventing mother-to-child transmission when the birth dose is given within 24 hours, cutting the risk of the baby becoming a chronic carrier by roughly half or more in field settings.
Effectiveness in Indian Field Programs
A large Indian retrospective cohort study found that universal infant hepatitis B vaccination significantly reduced markers of hepatitis B infection (anti-HBc) in children, showing clear program-level effectiveness in an Indian setting.
A Delhi-based study on vaccinated Indian children reported that about 69% had protective antibody levels after vaccination, but antibody levels declined with age, with only about 40% of children aged 9 to 10 years still having titers above the protective threshold.
Public Health Impact
Universal hepatitis B vaccination has helped lower the chronic HBV carrier rate and infection markers in Indian children, justifying its inclusion in the National Immunization Schedule. Most vaccinated children and adults develop good protection.
But a minority may not reach or maintain protective antibody levels, especially many years after vaccination. In routine practice, people are usually not revaccinated or given boosters unless they are in high-risk groups. e.g., dialysis patients, healthcare workers.
